General Information of the Compound
| Compound ID |
CP0287226
|
||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Compound Name |
methyl 2-phenyl-2-piperidin-2-ylacetate
Show/Hide
|
||||||||||||||||||
| Synonyms |
2-Piperidineacetic acid, .alpha.-phenyl-, methyl ester
2-Piperidineacetic acid, alpha-phenyl-, methyl ester
Alpha-Phenyl-2-piperidineacetic acid methyl ester
Alpha-Phenyl-alpha-(2-piperidyl)acetic acid methyl ester
Attenta (TN)
Biphentin (TN)
C 4311
Calocain
Centedein
Centedrin
Centredin
Concerta
Concerta (TN)
D-methylphenidate HCl
Daytrana
Daytrana (TN)
Equasym (TN)
METHYLPHENIDATE (SEE ALSO: METHYLPHENIDATE HYDROCHLORIDE, CAS 298-59-9, NTPNO 10266-R)
Meridil
Metadate
Metadate CD
Metadate ER
Metadate ER (TN)
Methyl (2-phenyl-2-(2-piperidyl)acetate)
Methyl 2-phenyl-2-piperidin-2-ylacetate
Methyl alpha-phenyl-alpha-(2-piperidyl)acetate
Methyl alpha-phenyl-alpha-2-piperidinylacetate
Methyl phenidate
Methyl phenidyl acetate
Methyl phenidylacetate
Methyl phenyl(piperidin-2-yl)acetate
Methylfenidan
Methylin
Methylin (TN)
Methylin ER
Methylofenidan
Methylphen
Methylphenidan
Methylphenidate
Methylphenidate (USAN/INN)
Methylphenidate [INN:BAN]
Methylphenidatum
Methylphenidatum [INN-Latin]
Metilfenidato
Metilfenidato [INN-Spanish]
Metilfenidato [Italian]
Motiron (TN)
PMS-Methylphenidate
Phenidylate
Plimasine
Riphenidate
Ritalin
Ritalin (TN)
Ritalin LA
Ritalin LA (TN)
Ritalin SR
Ritalin-SR
Ritaline
Ritcher works
Rubifen (TN)
Tsentedrin
Show/Hide
|
||||||||||||||||||
| Structure |
|
||||||||||||||||||
| Formula |
C14H19NO2
|
||||||||||||||||||
| Molecular Weight |
233.311
|
||||||||||||||||||
| Canonical SMILES |
COC(=O)C(C1CCCCN1)c1ccccc1
Show/Hide
|
||||||||||||||||||
| InChI |
InChI=1S/C14H19NO2/c1-17-14(16)13(11-7-3-2-4-8-11)12-9-5-6-10-15-12/h2-4,7-8,12-13,15H,5-6,9-10H2,1H3
Show/Hide
|
||||||||||||||||||
| InChIKey |
DUGOZIWVEXMGBE-UHFFFAOYSA-N
|
||||||||||||||||||
| CAS |
113-45-1
|
||||||||||||||||||
| Physicochemical Property |
"RO5" indicates the cutoff set by lipinski's rule of five: (1) Molecular weight less than 500 Dalton; (2) xlogp less than 5; (3) No more than 5 hbonddonor (Hydrogen Bond Donor Count); (4) No more than 10 hbondacc (Hydrogen Bond Acceptor Count); (5) No more than 10 rotbonds (Rotatable Bond Count). Show/Hide
|
||||||||||||||||||
| Click to Show/Hide the External Link(s) of This Compound | |||||||||||||||||||
| PubChem ID | |||||||||||||||||||
| ChEMBL ID | |||||||||||||||||||
| DrugBank ID | |||||||||||||||||||
Map of Molecular Bioactivity Related to the Compound
|
Map of Molecular Bioactivity Related to the Compound Compound Cell Line Protein Bioactivity Value: <= 0.1 μM > 0.1 μM and <= 10 μM > 10 μM Imprecise Activity |
|
|---|
Table of Molecular Bioactivities Related to the Compound
Protein ID: PT00884, Sodium-dependent dopamine transporter
Protein ID: PT01026, Sodium-dependent noradrenaline transporter
Protein ID: PT00871, Sodium-dependent serotonin transporter
Clinical Information about the Compound